This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lin, L. Articles by Nasjletti, A. Search for Related Content PubMed PubMed Citation Articles by Lin, L. Articles by Nasjletti, A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure

Hypertension, Vol 17, 517-525, Copyright © 1991 by American Heart Association

ARTICLES

Role of prostanoids in renin-dependent and renin-independent hypertension

L Lin, M Mistry, CT Stier Jr and A Nasjletti
Department of Pharmacology, New York Medical College, Valhalla.

We investigated the role of prostanoid-mediated pressor mechanisms in setting the level of blood pressure in renin-dependent and renin- independent models of hypertension in unanesthetized rats. Intravenous administration of a blocker of thromboxane A2/prostaglandin endoperoxide receptors, SQ29548 (2 mg/kg bolus injection plus 2 mg/kg/hr for 3 hours), reduced from 162 +/- 4 to 144 +/- 5 mm Hg (p less than 0.05) the blood pressure of rats with aortic coarctation- induced hypertension at 7-14 days after coarctation when plasma renin activity is greatly increased. In contrast, treatment with SQ29548 was without effect on the blood pressure of either normotensive or hypertensive rats (i.e., aortic coarctation-induced hypertension at 90- 113 days after coarctation, deoxycorticosterone-salt-induced hypertension) having normal or depressed values of plasma renin activity. The blood pressure-lowering effect of SQ29548 in the early phase of aortic coarctation-induced hypertension was positively correlated with the prevailing plasma renin activity and could not be demonstrated in hypertensive rats pretreated with indomethacin. We attribute the hypotensive effect of SQ29548 to interference with pressor mechanisms that depend on activation of thromboxane A2/prostaglandin endoperoxide receptors and suggest that such prostanoid-mediated mechanisms are operational and contribute to an increase in blood pressure in angiotensin-dependent forms of hypertension. Also prostanoid-mediated vasodepressor mechanisms are operational in the early phase of aortic coarctation-induced hypertension since the blood pressure of rats pretreated with SQ29548 was increased by the subsequent administration of indomethacin. Accordingly, the blood pressure of rats with aortic coarctation-induced hypertension is influenced by the interplay of prostanoid-mediated pressor and vasodepressor mechanisms.

This article has been cited by other articles:

				C. S. Wilcox and A. Pearlman Chemistry and Antihypertensive Effects of Tempol and Other Nitroxides Pharmacol. Rev., December 1, 2008; 60(4): 418 - 469. [Abstract] [Full Text] [PDF]

				W. J. Welch, K. Patel, P. Modlinger, M. Mendonca, N. Kawada, K. Dennehy, S. Aslam, and C. S. Wilcox Roles of vasoconstrictor prostaglandins, COX-1 and -2, and AT1, AT2, and TP receptors in a rat model of early 2K,1C hypertension Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2644 - H2649. [Abstract] [Full Text] [PDF]

				N. Kawada, K. Dennehy, G. Solis, P. Modlinger, R. Hamel, J. T. Kawada, S. Aslam, T. Moriyama, E. Imai, W. J. Welch, et al. TP receptors regulate renal hemodynamics during angiotensin II slow pressor response Am J Physiol Renal Physiol, October 1, 2004; 287(4): F753 - F759. [Abstract] [Full Text] [PDF]

				C. S. Wilcox and W. J. Welch Thromboxane synthase and TP receptor mRNA in rat kidney and brain: effects of salt intake and ANG II Am J Physiol Renal Physiol, March 1, 2003; 284(3): F525 - F531. [Abstract] [Full Text] [PDF]

				G. Arcaro, A. Solini, T. Monauni, A. Cretti, B. Brunato, A. Lechi, R. Fellin, M. Caputo, C. Cocco, E. Bonora, et al. ACE Genotype and Endothelium-Dependent Vasodilation of Conduit Arteries and Forearm Microcirculation in Humans Arterioscler Thromb Vasc Biol, August 1, 2001; 21(8): 1313 - 1319. [Abstract] [Full Text] [PDF]

				F. Stanke-Labesque, P. Devillier, P. Bedouch, J. L. Cracowski, O. Chavanon, and G. Bessard Angiotensin II-induced contractions in human internal mammary artery: effects of cyclooxygenase and lipoxygenase inhibition Cardiovasc Res, August 1, 2000; 47(2): 376 - 383. [Abstract] [Full Text] [PDF]

				M. D. Breyer and R. M. Breyer Prostaglandin E receptors and the kidney Am J Physiol Renal Physiol, July 1, 2000; 279(1): F12 - F23. [Abstract] [Full Text] [PDF]

				E.-C. Garcia-Cohen, J. Marin, L. D. Diez-Picazo, A. B. Baena, M. Salaices, and M. A. Rodriguez-Martinez Oxidative Stress Induced by tert-Butyl Hydroperoxide Causes Vasoconstriction in the Aorta from Hypertensive and Aged Rats: Role of Cyclooxygenase-2 Isoform J. Pharmacol. Exp. Ther., April 1, 2000; 293(1): 75 - 81. [Abstract] [Full Text]

				J.-L. Wang, H.-F. Cheng, and R. C. Harris Cyclooxygenase-2 Inhibition Decreases Renin Content and Lowers Blood Pressure in a Model of Renovascular Hypertension Hypertension, July 1, 1999; 34(1): 96 - 101. [Abstract] [Full Text] [PDF]

				L. V. d'Uscio, S. Shaw, M. Barton, and T. F. Luscher Losartan but Not Verapamil Inhibits Angiotensin II–Induced Tissue Endothelin-1 Increase : Role of Blood Pressure and Endothelial Function Hypertension, June 1, 1998; 31(6): 1305 - 1310. [Abstract] [Full Text] [PDF]

				D. H. Sigmon and W. H. Beierwaltes Influence of Nitric Oxide in the Chronic Phase of Two-Kidney, One Clip Renovascular Hypertension Hypertension, February 1, 1998; 31(2): 649 - 656. [Abstract] [Full Text] [PDF]

				A. Nasjletti The Role of Eicosanoids in Angiotensin-Dependent Hypertension Hypertension, January 1, 1998; 31(1): 194 - 200. [Abstract] [Full Text] [PDF]

				A. Dellipizzi, M. L. Pucci, A. Y. Mosny, K. Deseyn, and A. Nasjletti Contribution of Constrictor Prostanoids to the Calcium-Dependent Basal Tone in the Aorta from Rats with Aortic Coarctation-Induced Hypertension: Relationship to Nitric Oxide J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 75 - 81. [Abstract] [Full Text]

				P. Li, C. M. Ferrario, and K. B. Brosnihan J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1065 - 1070. [Abstract] [Full Text]

				H. J. Oskarsson and D. D. Heistad Oxidative Stress Produced by Angiotensin Too: Implications for Hypertension and Vascular Injury Circulation, February 4, 1997; 95(3): 557 - 559. [Full Text]

				H. Iwatsubo, M. Nagano, T. Sakai, K. Kumamoto, R. Morita, J. Higaki, T. Ogihara, and T. Hata Converting Enzyme Inhibitor Improves Forearm Reactive Hyperemia in Essential Hypertension Hypertension, January 1, 1997; 29(1): 286 - 290. [Abstract] [Full Text] [PDF]

				H. L. Keen, M. W. Brands, M. J. Smith Jr, E. W. Shek, and J. E Hall Thromboxane Is Required for Full Expression of Angiotensin Hypertension in Rats Hypertension, January 1, 1997; 29(1): 310 - 314. [Abstract] [Full Text] [PDF]

				S. Rajagopalan and D. G. Harrison Reversing Endothelial Dysfunction With ACE Inhibitors: A New TREND? Circulation, August 1, 1996; 94(3): 240 - 243. [Full Text]

				K. Bhagat, J. Collier, and P. Vallance Vasodilatation to Arachidonic Acid in Humans : An Insight Into Endogenous Prostanoids and Effects of Aspirin Circulation, October 15, 1995; 92(8): 2113 - 2118. [Abstract] [Full Text]

				D. H. Sigmon and W. H. Beierwaltes Endothelium-Derived Constricting Factor in Renovascular Hypertension Hypertension, April 1, 1995; 25(4): 803 - 808. [Abstract] [Full Text]